Sonnet BioTherapeutics Holdings, Inc.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025): $1.0M
Net Income/Loss (FY2025): -$16.0M
Total Assets (FY2025): $14.9M
Total Equity (FY2025): $10.8M
Cash Flows from Operating Activities (FY2025): -$12.8M

Source: Sonnet BioTherapeutics Holdings, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Sonnet BioTherapeutics Holdings, Inc.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025): $1.0M
Net Income/Loss (FY2025): -$16.0M
Total Assets (FY2025): $14.9M
Total Equity (FY2025): $10.8M
Cash Flows from Operating Activities (FY2025): -$12.8M

Source: Sonnet BioTherapeutics Holdings, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.